Differentiating Oral DMTs to Optimize Treatment Individualization with Drs. Stephen Krieger and Patricia K. Coyle

07/12/2022 15 min
Differentiating Oral DMTs to Optimize Treatment Individualization with Drs. Stephen Krieger and Patricia K. Coyle

Listen "Differentiating Oral DMTs to Optimize Treatment Individualization with Drs. Stephen Krieger and Patricia K. Coyle"

Episode Synopsis

In this podcast, expert clinicians will revisit an important topic from MS Forum® VIII, the use of current and emerging oral therapies for MS, including the Burton's tyrosine kinase (BTK) inhibitors.

More episodes of the podcast MedEdTalks - Neurology